y 27632 has been researched along with enalapril in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 6,311 | 1,924 | 859 |
Protein | Taxonomy | y 27632 (IC50) | enalapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayraktutan, U; Campbell, M; Mahadevan, VS; McKeown, PP | 1 |
1 other study(ies) available for y 27632 and enalapril
Article | Year |
---|---|
Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Amides; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cells, Cultured; Chemotaxis; Coronary Vessels; Enalapril; Farnesyltranstransferase; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Losartan; Mammary Arteries; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Pravastatin; Protein Serine-Threonine Kinases; Pyridines; Receptors, Oxidized LDL; rho-Associated Kinases | 2006 |